SCHEMBL333029

SCHEMBL333029

NCCCCNCCCNCCCN

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.93
CA6 P23280 5/20 0.93
CA7 P43166 5/20 0.93
CA9 Q16790 5/20 0.93
CA14 Q9ULX7 5/20 0.93
CA5B Q9Y2D0 5/20 0.93
CA2 P00918 4/20 0.93
CA4 P22748 4/20 0.93
CA5A P35218 4/20 0.93
ALOX15 P16050 3/20 0.93
CA3 P07451 3/20 0.93
F13A1 P00488 2/20 0.93
CYP1A2 P05177 2/20 0.93
THPO P40225 2/20 0.93
CA1 P00915 2/20 0.93
CYP2C9 P11712 1/20 0.93
PKM P14618 1/20 0.93
TSHR P16473 1/20 0.93
MTOR P42345 1/20 0.93
LMNA P02545 3/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3158875 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL3169101 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL3165616 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL3164546 0.97 CA12 (0.88) CA12CA6CA7CA9CA14
SCHEMBL4301760 0.97 CA12 (0.88) CA12CA6CA7CA9CA14
Hydrochloric Acid SCHEMBL31268131 0.97 LMNA (0.94) CA12CA6CA7CA9CA14
Spermine SCHEMBL288605 0.97 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL3159000 0.97 CA12 (0.93) CA12CA6CA7CA9CA14
Spermidine SCHEMBL8073115 0.97 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL3165201 0.97 CA12 (1.00) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731603-A1 LOW TEMPERATURE REACTIVE ARYL AZIDES SuSoS AG (CH) 2026-04-29 EP claimed
US-12586784-B2 Silicon anodes with water-soluble maleic anhydride-, and/or maleic acid-containing polymers/copolymers, derivatives, and/or combinations (with or without additives) as binders ENEVATE CORPORATION (US) 2026-03-24 US claimed
US-20260062715-A1 CATIONIC POLOXAMERS AND THEIR USE IN TRANSDUCTION OZ BIOSCIENCES (FR) 2026-03-05 US claimed
US-12441841-B2 Optically transparent polyimides AKRON POLYMER SYSTEMS, INC. (US) 2025-10-14 US claimed
WO-2025070707-A1 COMPOSITION CONTAINING DIAMINE AND/OR POLYAMINE FOR PREVENTING OR IMPROVING FRAILTY 東洋紡株式会社 2025-04-03 WO claimed
US-12215312-B2 Modified organisms for improved flavor and aroma RASPET SEAN (US) 2025-02-04 US claimed
WO-2024261308-A1 LOW TEMPERATURE REACTIVE ARYL AZIDES SUSOS AG (CH) 2024-12-26 WO claimed
US-20240379951-A1 SILICON ANODES WITH WATER-SOLUBLE MALEIC ANHYDRIDE-, AND/OR MALEIC ACID-CONTAINING POLYMERS/COPOLYMERS, DERIVATIVES, AND/OR COMBINATIONS (WITH OR WITHOUT ADDITIVES) AS BINDERS ENEVATE CORPORATION 2024-11-14 US claimed
US-20240335397-A1 USE OF POLYAMINES IN THE TREATMENT OF BRAIN TUMOURS CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-10-10 US claimed
US-20240309418-A1 ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA MASSACHUSETTS GEN HOSPITAL (US) 2024-09-19 US claimed
US-20220144747-A1 SHIKIMATE ANALOGUES AND METHODS OF USE THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2022-05-12 US claimed
CN-111479853-A Optically transparent polyimide 齐默尔根公司 2020-07-31 CN claimed
US-20200239635-A1 OPTICALLY TRANSPARENT POLYIMIDES AKRON POLYMER SYSTEMS, INC. 2020-07-30 US claimed
US-7452845-B2 Mesoporous organic-inorganic hybrid materials for separating gases CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-11-18 US claimed
US-20060281820-A1 Lfa-1 inhibitors and use thereof SODA KUNIYASU 2006-12-14 US claimed
EP-1370563-B1 MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES CENTRE NAT RECH SCIENT (FR) 2006-09-06 EP claimed
US-20040122250-A1 Mesoporous organic-inorganic hybrid materials for separating gases CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) 2004-06-24 US claimed
US-6172261-B1 BIOSYNTHESIS USING CHAIN EXTENSION ORIDIGM CORPORATION 2001-01-09 US claimed
EP-1001927-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 2000-05-24 EP claimed
WO-1999003823-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 1999-01-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122250-A1 Mesoporous organic-inorganic hybrid materials for separating gases SCO2, IPO9, IPO4 CA12 174/4885CA6 83/4885CA7 87/4885
US-12586784-B2 Silicon anodes with water-soluble maleic anhydride-, and/or maleic acid-containing polymers/copolymers, derivatives, and/or combinations (with or without additives) as binders ILK, CA1, STK11 CA12 12/4885CA6 201/4885CA7 58/4885
US-20260062715-A1 CATIONIC POLOXAMERS AND THEIR USE IN TRANSDUCTION TFRC, CD4, FTH1 CA12 968/4885CA6 644/4885CA7 2557/4885
US-20220144747-A1 SHIKIMATE ANALOGUES AND METHODS OF USE GRIK5, GRIK1, GRIK3 CA12 302/4885CA6 144/4885CA7 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.